One month in, and SpaceX is trading below its debut, barely above the $135 IPO price — while a single China rocket headline knocks 5% off the whole sector. For a stock priced for perfection, that's a very thin skin. If you're just joining: SpaceX went public in June, finally putting one of tech and aerospace's most anticipated private names into regular investors' accounts. But the story got wider than the stock — retail also got exposure through SPVs and tokenized wrappers, raising real questions about what they actually own, while the market argues over how much AI upside belongs in the number. This is where the moat argument gets stress-tested — China's Long March milestone, an oil spike, and a law firm now writing about Musk's control structure. Let's get into the tape. 24/7 Wall St., with David Moadel:
Shares of SpaceX (NASDAQ:SPCX) are down 5% to $138.58 in early Monday trading, a fresh record low that sits below the $150 debut price and well off the $225 peak on June 16. The slide extends a bruising stretch for the stock, which had already dropped 10% over the prior week.
The number that jumps out at me — Bernstein just named China as SpaceX's top rival after a Long March booster recovery, and SPCX drops 5% to a fresh record low. $138.58. Below the $150 debut. A stock priced for a near-perfect bull case, and one Bernstein note about somebody else's rocket knocks it below its debut. That's fragility, right there. But look at what got dragged with it — Rocket Lab down 4, AST down 5, the UFO ETF off 2 on an oil spike. SpaceX is trading like a line item in a space-sector basket. That's the mispricing. Or it's concentration risk finally showing up on the tape. When a Chinese milestone moves the whole complex in one session, sentiment is thinner than the bulls admitted. Meanwhile, Bank of America keeps a Buy on Rocket Lab, $115 target, through all of it. So the desks aren't panicking — the tape is. And on the listing side — a month ago this thing peaked at $225. It's now under the $150 debut. June's frenzy has fully unwound, and it only took one macro headline to do it. This one's from AOL:
But its main business is the manufacture and launch of rockets and telecommunications satellites called Starlink. When Starlink said it was cutting prices in the Memphis, Tennessee area amid local concerns over a massive data centre project, SpaceX shares fell on the day by 8%.
One month in, and here's the number that matters: SPCX priced at $135, opened at $150, ran to $225 that first week — and it hasn't once traded back down to that $135 IPO price. The retail get-in-early window? Thirty-two days, and it was already gone on day one. Right, and read the same tape a different way. A stock that ran to $225 and is now sitting in the $140s has given back almost everything beyond the original pricing. The $135 was the underwriter's math. Everything above it was the frenzy. But look at why it ran. CFRA's Keith Snyder says it straight — this was the first time retail felt they could buy an AI play. After the xAI acquisition folded in, retail bought the AI angle first. The rocket company part came second. Which is exactly my problem. You had a launch and defense company get repriced past Amazon and Microsoft after somebody slapped 'AI' on the deck. If the multiple is the story, it can crack fast. This month made that pretty clear. Fair — but the moat's still real underneath the hype. The market's just paying for it for the wrong reason. Here's Alon Y. Kapen at Mondaq:
SpaceX's recent IPO has drawn attention for its massive valuation and retail investor demand, but critical corporate governance provisions deserve closer scrutiny. The company's dual-class share structure grants Elon Musk 85% voting control despite holding only 42% equity, while mandatory arbitration clauses and Texas reincorporation create unprecedented barriers for public shareholders.
Here's what I've been waiting for — the governance argument has moved beyond podcast bears. Farrell Fritz is publishing that Musk holds 85% voting control on 42% equity. Put the dual-class structure next to mandatory arbitration and the Texas reincorporation, and public shareholders are boxed pretty far away from any real say. That belongs in a valuation model, not a footnote. And this is the one I've never waved off, Cassidy. Founder control I can defend all day — but 85 on 42 with arbitration clauses bolted on? That's a spread I can't hand-wave. What gets me is the timing. A month post-IPO, retail's already underwater, and now the legal read on control structure lands. The map showed up after the party started. Right. By the time the arbitration clause matters most, you've already lost the leverage to do anything about it. From Lucinda Shen at Axios:
The U.S. IPO market will set a new record by the end of this week, and the biggest AI IPOs remain in the offing. Why it matters: We've just crossed into the second half of the year.
So the whole 2026 IPO wave is about to top 2021 — $141.2 billion in proceeds, and Latham & Watkins is calling the SpaceX-to-SK Hynix run 'as much of a green light as you could possibly get.' Right, and the last time we set that record — $142.4 billion in 2021 — the party ended with a face-plant. Green light, sure. Nobody's mentioning the intersection. Fair. But look who's still in the pipeline — Anthropic, OpenAI. Saffos is basically saying investors bought SpaceX knowing those are coming. You can call it froth, but there's an actual queue behind it. A queue we're clearing with a Brookfield data-center operator and Standard Nuclear on the same Wednesday. When your record-breaker is Csquare raising $1.35 billion to push the tape over the line, that's a lot of weight on a rounding error. And notice the tell — Jersey Mike's and the Men's Wearhouse operator filing the same week. When sandwich shops crowd the runway behind SpaceX, the window's wide open. Now we find out who's late. Here's CryptoSlate:
The convergence on a single name reflects a structural ambiguity in how crypto exchanges and tokenization platforms label equity-linked instruments, and the most anticipated IPO in years put that ambiguity under the brightest possible light.
Okay, this is the one I've been waiting on. On IPO day, you could get 'SpaceX exposure' five different ways — actual Nasdaq shares, Backpack's redeemable token on Solana, xStocks certificates on Kraken and Bybit, a Binance campaign, and Hyperliquid perps. Five products, and they don't all give you the same thing. Right. And CryptoSlate finally puts a name to it — fragmented ownership and allocation. That's the crack. Four wrappers, four different claims on the same ticker. The Backpack one's actually clean — one-to-one backed by a real share in custody, through a regulated broker-dealer. But a perpetual future is not a share. A tracker certificate is not a share. And a lot of retail holders never learned the difference. That's the whole problem. When exposure and ownership get labeled with the same three letters, the retail buyer thinks they own something they don't. The IPO just turned the lights on. And this ties back to the SPV wrapper mess we were flagging, the murky pre-IPO transactions. Now it's a public company, and the ambiguity didn't resolve. It just got a new venue and a name. Eric, you called this the actual crack, not the hypothetical. You're right. When someone holding a Hyperliquid perp finds out their 'stock' has no shareholder rights, the footnote turns into a support ticket at scale. If SpaceX IPO Watch helps you stay ahead of the story, take a moment to subscribe or leave a review wherever you’re listening. It really helps other people find the show.
Next, we're watching Csquare. It's expected to raise up to $1.35 billion in its IPO on July 15, a deal Axios says would push 2026 U.S. IPO proceeds past the 2021 record.
You’ll find links to every story we covered today in the show notes, so you can spend more time with anything that caught your ear. That’s SpaceX IPO Watch for today. This is a Lantern Podcast.